Search

Your search keyword '"Itoh, Kyogo"' showing total 1,034 results
Start Over Author "Itoh, Kyogo"
1,034 results on '"Itoh, Kyogo"'

111. Expression of tumor rejection antigens in colorectal carcinomas

Author

Sasatomi, Teruo, Suefuji, Yuichi, Matsunaga, Kazuko, Yamana, Hideaki, Miyagi, Yoshiaki, Araki, Yasumi, Ogata, Yutaka, Itoh, Kyogo, and Shirouzu, Kazuo

Subjects
Colorectal cancer -- Care and treatment, Immunotherapy -- Research, Tumor antigens -- Physiological aspects, Health
Published
2002

115. Cancer classification using the Immunoscore: a worldwide task force

Author

Galon Jérôme, Pagès Franck, Marincola Francesco M, Angell Helen K, Thurin Magdalena, Lugli Alessandro, Zlobec Inti, Berger Anne, Bifulco Carlo, Botti Gerardo, Tatangelo Fabiana, Britten Cedrik M, Kreiter Sebastian, Chouchane Lotfi, Delrio Paolo, Arndt Hartmann, Asslaber Martin, Maio Michele, Masucci Giuseppe V, Mihm Martin, Vidal-Vanaclocha Fernando, Allison James P, Gnjatic Sacha, Hakansson Leif, Huber Christoph, Singh-Jasuja Harpreet, Ottensmeier Christian, Zwierzina Heinz, Laghi Luigi, Grizzi Fabio, Ohashi Pamela S, Shaw Patricia A, Clarke Blaise A, Wouters Bradly G, Kawakami Yutaka, Hazama Shoichi, Okuno Kiyotaka, Wang Ena, O'Donnell-Tormey Jill, Lagorce Christine, Pawelec Graham, Nishimura Michael I, Hawkins Robert, Lapointe Réjean, Lundqvist Andreas, Khleif Samir N, Ogino Shuji, Gibbs Peter, Waring Paul, Sato Noriyuki, Torigoe Toshihiko, Itoh Kyogo, Patel Prabhu S, Shukla Shilin N, Palmqvist Richard, Nagtegaal Iris D, Wang Yili, D'Arrigo Corrado, Kopetz Scott, Sinicrope Frank A, Trinchieri Giorgio, Gajewski Thomas F, Ascierto Paolo A, and Fox Bernard A

Subjects
Medicine
Abstract

Abstract Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor staging (AJCC/UICC-TNM classification) summarizes data on tumor burden (T), presence of cancer cells in draining and regional lymph nodes (N) and evidence for metastases (M). However, it is now recognized that clinical outcome can significantly vary among patients within the same stage. The current classification provides limited prognostic information, and does not predict response to therapy. Recent literature has alluded to the importance of the host immune system in controlling tumor progression. Thus, evidence supports the notion to include immunological biomarkers, implemented as a tool for the prediction of prognosis and response to therapy. Accumulating data, collected from large cohorts of human cancers, has demonstrated the impact of immune-classification, which has a prognostic value that may add to the significance of the AJCC/UICC TNM-classification. It is therefore imperative to begin to incorporate the ‘Immunoscore’ into traditional classification, thus providing an essential prognostic and potentially predictive tool. Introduction of this parameter as a biomarker to classify cancers, as part of routine diagnostic and prognostic assessment of tumors, will facilitate clinical decision-making including rational stratification of patient treatment. Equally, the inherent complexity of quantitative immunohistochemistry, in conjunction with protocol variation across laboratories, analysis of different immune cell types, inconsistent region selection criteria, and variable ways to quantify immune infiltration, all underline the urgent requirement to reach assay harmonization. In an effort to promote the Immunoscore in routine clinical settings, an international task force was initiated. This review represents a follow-up of the announcement of this initiative, and of the J Transl Med. editorial from January 2012. Immunophenotyping of tumors may provide crucial novel prognostic information. The results of this international validation may result in the implementation of the Immunoscore as a new component for the classification of cancer, designated TNM-I (TNM-Immune).

Published
2012
Full Text
View/download PDF

116. Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides

Author

Fukui Akimasa, Matsueda Satoko, Kawano Kouichiro, Tsuda Naotake, Komatsu Nobukazu, Shichijo Shigeki, Sasada Tetsuro, Hattori Satoshi, Ushijima Kimio, Itoh Kyogo, and Kamura Toshiharu

Subjects
Human papillomavirus, Prophylactic vaccine, Anti-peptide antibody, Virus-like particles, Infectious and parasitic diseases, RC109-216
Abstract

Abstract Background Persistent infection of human papillomavirus (HPV) types 16 and 18 causes cervical cancer. To better understand immune responses to the prophylactic vaccine, HPV 16/18 L1 virus-like particles (HPV-VLPs), we investigated B cell epitopes of HPV16 L1-derived peptides. Methods Sera from mice immunized with HPV-16/18 L1 VLPs were analyzed for their IgG titers against 10 different HPV16 L1-derived peptides (20-mer) that contain human leukocyte antigen (HLA)-class I A-2, A-24 and class II DR. Results One 20-mer peptide at positions 300 to 319 was identified as a common B cell epitope in both Balb/c (H-2d) and C57BL/6 (H-2b) mice. Mapping analysis showed that the 10-amino-acid sequence at positions 304to 313 was an immunogenic portion. It is of note that the binding capability of this 10-mer peptide to the HLA-A2 and HLA-A24 molecules was confirmed by the HLA class I stabilization assay. In addition, one unique 20-mer was determined as a B cell epitope in each strain. Conclusions These results might provide new information for better understanding of immune responses to HPV 16 L1.

Published
2012
Full Text
View/download PDF

118. Personalized peptide vaccination for castration-resistant prostate cancer progressing after docetaxel chemotherapy: A randomized, double-blind, placebo-controlled, phase III trial.

Author

Noguchi, Masanori, primary, Fujimoto, Kiyohide, additional, Arai, Gaku, additional, Uemura, Hiroji, additional, Hashine, Katsuyoshi, additional, Matsumoto, Hiroaki, additional, Fukasawa, Satoshi, additional, Nakatsu, Hideomi, additional, Takenaka, Atsushi, additional, Fujisawa, Masato, additional, Uemura, Hirotsugu, additional, Naito, Seiji, additional, Egawa, Shin, additional, Fujimoto, Hiroyuki, additional, Hinotsu, Shiro, additional, Itoh, Kyogo, additional, and Kohjimoto, Yasuo, additional

Published
2019
Full Text
View/download PDF

120. Personalised Peptide Vaccination for Castration-Resistant Prostate Cancer Progressing after Docetaxel Chemotherapy: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial

Author

Noguchi, Masanori, primary, Fujimoto, Kiyohide Fujimoto, additional, Arai, Gaku, additional, Uemura, Hiroji, additional, Hashine, Katsuyoshi, additional, Matsumoto, Hiroaki, additional, Fukasawa, Satoshi, additional, Kohjimoto, Yasuo, additional, Nakatsu, Hideomi, additional, Takenaka, Atsushi, additional, Fujusawa, Masato, additional, Uemura, Hirotsugu, additional, Naito, Seiji, additional, Egawa, Shin, additional, Fujimoto, Hiroyuki, additional, Hinotsu, Shiro, additional, and Itoh, Kyogo, additional

Published
2019
Full Text
View/download PDF

130. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers

Author

Balch, Charles M., Riley, Lee B., Bae, Yoon Joo, Salmeron, Marie A., Platsoucas, Chris D., von Eschenbach, Andrew, and Itoh, Kyogo

Subjects
Cancer -- Research, Interleukin-2 -- Health aspects, Tumor-infiltrating lymphocytes -- Physiological aspects, Health
Abstract

Each type of cancer tissue has its own biologic characteristics, and different cancers elicit different host responses at a cellular level. In studying host-tumor relationships, an important area of investigation is tumor-infiltrating lymphocytes (a type of white blood cells) and relationships between cellular immune response and the characteristics of surrounding tumor cells. Analysis of tumor-infiltrating lymphocytes (TILs) may provide new information on how to stimulate them to reject the cancer cells surrounding them. It has been noted that there are distinct patterns of TILs for different cancers. A systematic examination was undertaken to compare the yield, type and function of TILS obtained from more than 120 different samples of human cancer. These cancers included melanomas, breast cancer, renal cell cancer, colon cancer and sarcoma. The percent of lymphocytes recovered varied; for renal cell it was 65 percent; for breast cancer, 45 percent; for primary melanoma, 35 percent; for metastatic melanoma, 30 percent; and for sarcomas, 36 percent. Interleukin 2 (IL-2) was used to activate TILs; before and after activation the types of lymphocytes showed specific patterns. There was much diversity of TILs among the different cancers in terms of the extent of lymphocyte infiltration, observable characteristics, and function. These results may have treatment applications. IL-2 played a major role in increasing the effectiveness of cytotoxicity (toxicity to cells) among all the TIL specimens studied. IL-2 probably should have a major role in a multiagent biologic therapy regimen. (Consumer Summary produced by Reliance Medical Information, Inc.)

Published
1990

131. A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma

Author

Narita, Yoshitaka, primary, Arakawa, Yoshiki, additional, Yamasaki, Fumiyuki, additional, Nishikawa, Ryo, additional, Aoki, Tomokazu, additional, Kanamori, Masayuki, additional, Nagane, Motoo, additional, Kumabe, Toshihiro, additional, Hirose, Yuichi, additional, Ichikawa, Tomotsugu, additional, Kobayashi, Hiroyuki, additional, Fujimaki, Takamitsu, additional, Goto, Hisaharu, additional, Takeshima, Hideo, additional, Ueba, Tetsuya, additional, Abe, Hiroshi, additional, Tamiya, Takashi, additional, Sonoda, Yukihiko, additional, Natsume, Atsushi, additional, Kakuma, Tatsuyuki, additional, Sugita, Yasuo, additional, Komatsu, Nobukazu, additional, Yamada, Akira, additional, Sasada, Tetsuro, additional, Matsueda, Satoko, additional, Shichijo, Shigeki, additional, Itoh, Kyogo, additional, and Terasaki, Mizuhiko, additional

Published
2018
Full Text
View/download PDF

134. Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: A randomized, double-blind, placebo-controlled, phase 2 trial.

Author

Noguchi, Masanori, primary, Arai, Gaku, additional, Egawa, Shin, additional, Ohyama, Chikara, additional, Naito, Seiji, additional, Matsumoto, Kazumasa, additional, Uemura, Hirotsugu, additional, Nakagawa, Masayuki, additional, Nasu, Yasutomo, additional, Eto, Masatoshi, additional, Suekane, Shigetaka, additional, Sasada, Tetsuro, additional, Shichijo, Shigeki, additional, Yamada, Akira, additional, Kakuma, Tatsuyuki, additional, and Itoh, Kyogo, additional

Published
2018
Full Text
View/download PDF

141. A randomized phase II trial of personalized peptide vaccine with low dose cyclophosphamide in biliary tract cancer

Author

Shirahama, Takahisa, primary, Muroya, Daisuke, additional, Matsueda, Satoko, additional, Yamada, Akira, additional, Shichijo, Shigeki, additional, Naito, Masayasu, additional, Yamashita, Takuto, additional, Sakamoto, Shinjiro, additional, Okuda, Koji, additional, Itoh, Kyogo, additional, Sasada, Tetsuro, additional, and Yutani, Shigeru, additional

Published
2017
Full Text
View/download PDF

142. Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11+ or -A33+ allele

Author

Sakamoto, Shinjiro, primary, Matsueda, Satoko, additional, Takamori, Shinzo, additional, Toh, Uhi, additional, Noguchi, Masanori, additional, Yutani, Shigeru, additional, Yamada, Akira, additional, Shichijo, Shigeki, additional, Yamada, Teppei, additional, Suekane, Shigetaka, additional, Kawano, Kouichiro, additional, Naitou, Masayasu, additional, Sasada, Tetsuro, additional, Hattori, Noboru, additional, Kohno, Nobuoki, additional, and Itoh, Kyogo, additional

Published
2017
Full Text
View/download PDF

143. MP78-06 PHASE II STUDY OF PERSONALIZED PEPTIDE VACCINATION FOR METASTATIC UPPER TRACT UROTHELIAL CANCER PATIENTS REFRACTORY TO THE STANDARD CHEMOTHERAPY

Author

Suekane, Shigetaka, primary, Ueda, Kousuke, additional, Nishihara, Kiyoaki, additional, Igawa, Tsukasa, additional, Noguchi, Masanori, additional, Sasada, Tetsuro, additional, Yamashita, Takuto, additional, Yutani, Shigeru, additional, Shichijo, Shigeki, additional, and Itoh, Kyogo, additional

Published
2017
Full Text
View/download PDF

146. Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females

Author

Yokomine, Masato, primary, Matsueda, Satoko, additional, Kawano, Kouichiro, additional, Sasada, Tetsuro, additional, Fukui, Akimasa, additional, Yamashita, Takuto, additional, Komatsu, Nobukazu, additional, Shichijo, Shigeki, additional, Tasaki, Kazuto, additional, Matsukuma, Ken, additional, Itoh, Kyogo, additional, Kamura, Toshiharu, additional, and Ushijima, Kimio, additional

Published
2017
Full Text
View/download PDF

150. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Author

Althammer, Sonja, primary, Steele, Keith, additional, Rebelatto, Marlon, additional, Tan, Tze Heng, additional, Wiestler, Tobias, additional, Schmidt, Guenter, additional, Higgs, Brandon, additional, Li, Xia, additional, Shi, Li, additional, Jin, Xiaoping, additional, Antal, Joyce, additional, Gupta, Ashok, additional, Ranade, Koustubh, additional, Binning, Gerd, additional, Bellmunt, Joaquim, additional, de Wit, Ronald, additional, Vaughn, David J., additional, Fradet, Yves, additional, Lee, Jae Lyun, additional, Fong, Lawrence, additional, Vogelzang, Nicholas J., additional, Climent, Miguel A., additional, Petrylak, Daniel P., additional, Choueiri, Toni K., additional, Necchi, Andrea, additional, Gerritsen, Winald, additional, Gurney, Howard, additional, Quinn, David I., additional, Culine, Stéphane, additional, Sternberg, Cora N., additional, Mai, Yabing, additional, Puhlmann, Markus, additional, Perini, Rodolfo F., additional, Bajorin, Dean F., additional, Sharma, Padmanee, additional, Callahan, Margaret K., additional, Calvo, Emiliano, additional, Kim, Joseph W., additional, de Braud, Filipo, additional, Ott, Patrick A., additional, Bono, Petri, additional, Pillai, Rathi N., additional, Morse, Michael, additional, Le, Dung T., additional, Taylor, Matthew, additional, Spilliopoulou, Pavlina, additional, Bendell, Johanna, additional, Jaeger, Dirk, additional, Chan, Emily, additional, Antonia, Scott J., additional, Ascierto, Paolo A., additional, Hennicken, Delphine, additional, Tschaika, Marina, additional, Azrilevich, Alex, additional, Rosenberg, Jonathan, additional, Levy, Ofer, additional, Chan, Christopher, additional, Cojocaru, Gady, additional, Liang, Spencer, additional, Ophir, Eran, additional, Ganguly, Sudipto, additional, Toporik, Amir, additional, Kotturi, Maya, additional, Kfir, Tal Fridman, additional, Murter, Benjamin M., additional, Logronio, Kathryn, additional, Dassa, Liat, additional, Leung, Ling, additional, Greenwald, Shirley, additional, Azulay, Meir, additional, Kumar, Sandeep, additional, Alteber, Zoya, additional, Pan, Xiaoyu, additional, Machlenkin, Arthur, additional, Benita, Yair, additional, Drake, Andrew W., additional, Chajut, Ayelet, additional, Salomon, Ran, additional, Vankin, Ilan, additional, Safyon, Einav, additional, Hunter, John, additional, Levine, Zurit, additional, White, Mark, additional, Leidner, Rom, additional, Kang, Hyunseok, additional, Haddad, Robert, additional, Segal, Neil H., additional, Wirth, Lori J., additional, Ferris, Robert L., additional, Hodi, F. Stephen, additional, Sanborn, Rachel E., additional, Gajewski, Thomas F., additional, Sharfman, William, additional, McDonald, Dan, additional, Srivastava, Shivani, additional, Gu, Xuemin, additional, Phillips, Penny, additional, Passey, Chaitali, additional, Seiwert, Tanguy, additional, Habtetsion, Tsadik, additional, Zhou, Gang, additional, Sakellariou-Thompson, Donastas, additional, Haymaker, Cara, additional, Creasy, Caitlin, additional, Hurd, Mark, additional, Uraoka, Naohiro, additional, Canales, Jaime Rodriguez, additional, Koptez, Scott, additional, Hwu, Patrick, additional, Maitra, Anirban, additional, Bernatchez, Chantale, additional, Coyle, Scott M., additional, Roybel, Kole T., additional, Rupp, Levi J., additional, Santoro, Stephen P., additional, Secrest, Stephanie, additional, Spelman, Michael, additional, Ho, Hanson, additional, Gomes, Tina, additional, Tse, Tiffany, additional, Yung-Wu, Chia, additional, Taunton, Jack, additional, Lim, Wendell, additional, Emtage, Peter, additional, Moudgil, Tarsem, additional, Ballesteros-Merino, Carmen, additional, Hilton, Traci, additional, Paustian, Christopher, additional, Page, David, additional, Urba, Walter, additional, Fox, Bernard, additional, Bell, Bryan, additional, Patel, Ashish, additional, Olafsen, Tove, additional, Satpayev, Daulet, additional, Torgov, Michael, additional, Marchioni, Filippo, additional, Romero, Jason, additional, Jiang, Ziyue Karen, additional, Zamilpa, Charles, additional, Keppler, Jennifer S., additional, Mascioni, Alessandro, additional, Jia, Fang, additional, Lee, Chen-Yu, additional, Gudas, Jean, additional, Sullivan, Ryan J., additional, Hoshida, Yujin, additional, Logan, Theodore, additional, Khushalani, Nikhil, additional, Giobbie-Hurder, Anita, additional, Margolin, Kim, additional, Roder, Joanna, additional, Bhatt, Rupal, additional, Koon, Henry, additional, Olencki, Thomas, additional, Hutson, Thomas, additional, Curti, Brendan, additional, Blackmon, Shauna, additional, Mier, James W., additional, Puzanov, Igor, additional, Roder, Heinrich, additional, Stewart, John, additional, Amin, Asim, additional, Ernstoff, Marc S., additional, Clark, Joseph I., additional, Atkins, Michael B., additional, Kaufman, Howard L., additional, Sosman, Jeffrey, additional, Signoretti, Sabina, additional, McDermott, David F., additional, Anderson, Abraham A., additional, Milhem, Mohammed M., additional, Andtbacka, Robert H. I., additional, Minor, David, additional, Gorski, Kevin S., additional, Baker, Daniel M., additional, Hamid, Omid, additional, Akporiaye, Emmanuel, additional, Koguchi, Yoshinobu, additional, Sutcliffe, Kim, additional, Conder, Kristie, additional, Marron, Thomas, additional, Bhardwaj, Nina, additional, Hammerich, Linda, additional, George, Fiby, additional, Kim-Schulze, Seunghee, additional, Keler, Tibor, additional, Davis, Tom, additional, Crowley, Elizabeth, additional, Salazar, Andres, additional, Brody, Joshua, additional, Monjazeb, Arta, additional, Daly, Megan E., additional, Riess, Jonathan, additional, Li, Tianhong, additional, Murphy, William J., additional, Kelly, Karen, additional, Hu, Zhiwei, additional, Shen, Rulong, additional, Campbell, Amanda, additional, McMichael, Elizabeth, additional, Yu, Lianbo, additional, Ramaswam, Bhuvaneswari, additional, London, Cheryl A., additional, Xu, Tian, additional, Carson, William, additional, Kokolus, Kathleen M., additional, Repasky, Elizabeth A., additional, Schell, Todd D., additional, Drabick, Joseph D., additional, Messenheimer, David J., additional, Jensen, Shawn, additional, Rubinstein, Mark, additional, Andrijauskaite, Kristina, additional, Swiderska-syn, Marzena, additional, Lind, Kristin, additional, Choppin, Agnes, additional, Roell, Marina K., additional, Wrangle, John, additional, Rhode, Peter, additional, Wong, Hing, additional, Ahmad, Shamim, additional, Webb, Mason, additional, Abu-Eid, Rasha, additional, Shrimali, Rajeev, additional, Verma, Vivek, additional, Doroodchi, Atbin, additional, Berrong, Zuzana, additional, Yashar, David, additional, Samara, Raed, additional, Mkrtichyan, Mikayel, additional, Khleif, Samir, additional, Powell, Steven, additional, Gitau, Mark, additional, Sumey, Christopher, additional, Terrell, Andrew, additional, Lohr, Michele, additional, Nowak, Ryan K., additional, McGraw, Steven, additional, Jensen, Ash, additional, Blanchard, Miran, additional, Gold, Kathryn A., additional, Cohen, Ezra E. W., additional, Ellison, Christie, additional, Black, Lora, additional, Lee, John, additional, Spanos, William Chad, additional, Wennerberg, Erik, additional, Schwitzer, Emily, additional, Lhuillier, Claire, additional, Koelwyn, Graeme, additional, Hiner, Rebecca, additional, Jones, Lee, additional, Demaria, Sandra, additional, Amanda, Vandeveer, additional, Greiner, John W., additional, Schlom, Jeffrey, additional, Bookstaver, Michelle, additional, Jewell, Christopher M., additional, Gunderson, Andrew, additional, Boulmay, Brian, additional, Li, Rui, additional, Spieler, Bradley, additional, Happel, Kyle, additional, Feng, Zipei, additional, Dubay, Christopher, additional, Fisher, Brenda, additional, Aung, Sandra, additional, Mederos, Eileen, additional, Bifulco, Carlo B., additional, McNamara, Michael, additional, Bahjat, Keith, additional, Redmond, William, additional, Ochoa, Augusto, additional, Hu, Hong-Ming, additional, Mehta, Adi, additional, Lund-Johansen, Fridtjof, additional, Bedu-Addo, Frank, additional, Conn, Greg, additional, King, Michael, additional, Dutta, Panna, additional, Shepard, Robert, additional, Einstein, Mark, additional, Adams, Sylvia, additional, Wang, Ena, additional, Jin, Ping, additional, Novik, Yelena, additional, Morrison, Debra, additional, Oratz, Ruth, additional, Marincola, Franco M., additional, Stroncek, David, additional, Goldberg, Judith, additional, Formenti, Silvia C., additional, Galon, Jérôme, additional, Mlecnik, Bernhard, additional, Marliot, Florence, additional, Ou, Fang-Shu, additional, Lugli, Alessandro, additional, Zlobec, Inti, additional, Rau, Tilman T., additional, Nagtegaal, Iris D., additional, Vink-Borger, Elisa, additional, Hartmann, Arndt, additional, Geppert, Carol, additional, Roehrl, Michael H., additional, Bavi, Prashant, additional, Ohashi, Pamela S., additional, Wang, Julia Y., additional, Nguyen, Linh T., additional, Han, SeongJun, additional, MacGregor, Heather L., additional, Hafezi-Bakhtiari, Sara, additional, Wouters, Bradley G., additional, Kawakami, Yutaka, additional, Papivanova, Boryana, additional, Xu, Mingli, additional, Fujita, Tomonobu, additional, Hazama, Shoichi, additional, Suzuki, Nobuaki, additional, Nagano, Hiroaki, additional, Okuno, Kiyotaka, additional, Itoh, Kyogo, additional, Zavadova, Eva, additional, Vocka, Michal, additional, Spacek, Jan, additional, Petruzelka, Lubos, additional, Konopasek, Bohuslav, additional, Dundr, Pavel, additional, Skalova, Helena, additional, Torigoe, Toshihiko, additional, Sato, Noriyuki, additional, Furuhata, Tomohisa, additional, Takemasa, Ichiro, additional, Van den Eynde, Marc, additional, Jouret-Mourin, Anne, additional, Machiels, Jean-Pascal, additional, Fredriksen, Tessa, additional, Lafontaine, Lucie, additional, Buttard, Bénédicte, additional, Church, Sarah, additional, Maby, Pauline, additional, Angell, Helen, additional, Angelova, Mihaela, additional, Vasaturo, Angela, additional, Bindea, Gabriela, additional, Berger, Anne, additional, Lagorce, Christine, additional, Patel, Prabhu S., additional, Vora, Hemangini H., additional, Shah, Birva, additional, Patel, Jayendrakumar B., additional, Rajvik, Kruti N., additional, Pandya, Shashank J., additional, Shukla, Shilin N., additional, Wang, Yili, additional, Zhang, Guanjun, additional, Masucci, Giuseppe V., additional, Andersson, Emilia K., additional, Grizzi, Fabio, additional, Laghi, Luigi, additional, Botti, Gerardo, additional, Tatangelo, Fabiana, additional, Delrio, Paolo, additional, Cilberto, Gennaro, additional, Marincola, Franco, additional, Sargent, Daniel J., additional, Fox, Bernard A., additional, Algazi, Alain, additional, Tsai, Katy, additional, Rosenblum, Michael, additional, Nandoskar, Prachi, additional, Li, Amy, additional, Nonomura, John, additional, Takamura, Kathryn, additional, Dwyer, Mary, additional, Browning, Erica, additional, Talia, Reneta, additional, Twitty, Chris, additional, Gargosky, Sharron, additional, Campbell, Jean, additional, Le, Mai, additional, Pierce, Robert H., additional, Daud, Adil, additional, Gartrell, Robyn, additional, Marks, Douglas, additional, Stack, Edward, additional, Lu, Yan, additional, Izaki, Daisuke, additional, Beck, Kristen, additional, Jia, Dan Tong, additional, Armenta, Paul, additional, White-Stern, Ashley, additional, Fu, Yichun, additional, Blake, Zoe, additional, Taback, Bret, additional, Horst, Basil, additional, Saenger, Yvonne M., additional, Leonardo, Steven, additional, Gorden, Keith, additional, Fulton, Ross B., additional, Fraser, Kathryn, additional, Kangas, Takashi O., additional, Walsh, Richard, additional, Ertelt, Kathleen, additional, Graff, Jeremy, additional, Uhlik, Mark, additional, Sims, Jennifer S., additional, Lei, Liang, additional, Tsujiuchi, Takashi, additional, Bruce, Jeffrey N., additional, Canoll, Peter, additional, Tolcher, Anthony W, additional, Alley, Evan W, additional, Chichili, Gurunadh, additional, Canoll, Jan E, additional, Moore, Paul, additional, Bonvini, Ezio, additional, Johnson, Syd, additional, Shankar, Sadhna, additional, Vasselli, James, additional, Wigginton, Jon, additional, and Powderly, John, additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results